Eleni Douni Selected Research

Dinoprostone (PGE2)

1/2004

Effect of phospholipase A2 inhibitory peptide on inflammatory arthritis in a TNF transgenic mouse model: a time-course ultrastructural study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eleni Douni Research Topics

Disease

5	Osteoporosis 12/2021 - 07/2013
5	Arthritis (Polyarthritis) 12/2015 - 01/2004
4	Bone Resorption 01/2019 - 02/2012
2	Postmenopausal Osteoporosis 10/2020 - 01/2014
2	Neuromuscular Diseases (Neuromuscular Disease) 11/2019 - 01/2014
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2018
2	Crohn Disease (Crohn's Disease) 01/2018 - 11/2002
2	Disease Progression 12/2015 - 11/2002
2	Rheumatoid Arthritis 01/2009 - 01/2004
2	Osteoarthritis 01/2009 - 01/2004
2	Synovitis 01/2004 - 01/2004
1	Hyperinsulinism (Hyperinsulinemia) 12/2021
1	Weight Gain 12/2021
1	Metabolic Diseases (Metabolic Disease) 12/2021
1	Body Weight (Weight, Body) 12/2021
1	Neoplasms (Cancer) 01/2020
1	Anorexia 01/2020
1	Muscle Weakness 01/2019
1	Atrophy 01/2019
1	Sarcopenia 01/2019
1	Muscular Dystrophies (Muscular Dystrophy) 01/2019
1	Insulin Resistance 01/2019
1	Multiple Sclerosis 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Psoriatic Arthritis 01/2018
1	Pontocerebellar Hypoplasia 01/2017
1	Leigh Disease (Leigh's Disease) 01/2017
1	Ataxia (Dyssynergia) 01/2017
1	Optic Atrophy 01/2017
1	Bone Diseases (Bone Disease) 01/2014
1	Osteopetrosis 02/2012
1	Inflammation (Inflammations) 01/2009
1	Ischemia 01/2003
1	Central Nervous System Diseases (CNS Diseases) 01/2003
1	Wasting Syndrome (Wasting Disease) 11/2002
1	Colitis 11/2002

Drug/Important Bio-Agent (IBA)

8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 11/2002
6	LigandsIBA 01/2021 - 02/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 01/2004
2	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2009
2	CytokinesIBA 07/2013 - 11/2002
2	Secretory Phospholipases A2IBA 01/2009 - 01/2004
2	Peptides (Polypeptides)IBA 01/2009 - 01/2004
1	Insulin (Novolin)FDA Link 12/2021
1	GlucocorticoidsIBA 12/2021
1	Pharmaceutical PreparationsIBA 10/2020
1	Monoclonal AntibodiesIBA 10/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	ThiazolidinedionesIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2019
1	Protein Tyrosine PhosphatasesIBA 01/2019
1	MyostatinIBA 01/2019
1	Denosumab FDA Link 01/2019
1	Tumor Necrosis Factor InhibitorsIBA 01/2018
1	RANK LigandIBA 01/2018
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2017
1	Etanercept (Enbrel)FDA Link 12/2015
1	Phosphotransferases (Kinase)IBA 12/2015
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2014
1	Essential Amino AcidsIBA 02/2012
1	Phospholipases (Phospholipase)IBA 01/2009
1	InterleukinsIBA 01/2009
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2009
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2009
1	Matrix Metalloproteinases (MMPs)IBA 01/2009
1	Matrix Metalloproteinase InhibitorsIBA 01/2009
1	TristetraprolinIBA 10/2006
1	Methotrexate (Mexate)FDA LinkGeneric 01/2004
1	ProstaglandinsIBA 01/2004
1	Dinoprostone (PGE2)FDA Link 01/2004
1	Therapeutic UsesIBA 01/2004
1	LipopolysaccharidesIBA 01/2004
1	diacereinIBA 01/2004
1	Phospholipases A2 (Phospholipase A2)IBA 01/2004
1	Arachidonic Acid (Vitamin F)IBA 01/2004
1	Type II Tumor Necrosis Factor ReceptorsIBA 11/2002

Therapy/Procedure

2	Therapeutics 12/2015 - 01/2004
1	Drug Therapy (Chemotherapy) 01/2020
1	Denervation 01/2019